-
1
-
-
67749134847
-
Diffuse large B-cell lymphoma,not otherwise specified
-
S.H. Swerdlow E. Campo N.L. Harris (eds) et al. 4 International Agency for Research on Cancer (IARC) Lyon
-
Stein H, Warnke RA, Chan WC, Jaffe ES, Chan JKC, Gatter KC, Campo E (2008) Diffuse large B-cell lymphoma,not otherwise specified. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tisseus, 4th edn. International Agency for Research on Cancer (IARC), Lyon, pp 233-237
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tisseus
, pp. 233-237
-
-
Stein, H.1
Warnke, R.A.2
Chan, W.C.3
Jaffe, E.S.4
Chan, J.K.C.5
Gatter, K.C.6
Campo, E.7
-
2
-
-
30744438321
-
Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma
-
10.1002/cncr.21586 1:CAS:528:DC%2BD28XjslOmtbc%3D 16342164 10.1002/cncr.21586
-
Wu G, Keating A (2006) Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma. Cancer 106:247-257. doi: 10.1002/cncr.21586
-
(2006)
Cancer
, vol.106
, pp. 247-257
-
-
Wu, G.1
Keating, A.2
-
3
-
-
20144382754
-
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
-
10.1182/blood-2004-07-2947 1:CAS:528:DC%2BD2MXitVOnsrY%3D 15550490 10.1182/blood-2004-07-2947
-
Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, Dal Cin P, Ladd C, Pinkus GS, Salles G, Harris NL, Dalla-Favera R, Habermann TM, Aster JC, Golub TR, Shipp MA (2005) Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105:1851-1861. doi: 10.1182/blood-2004-07-2947
-
(2005)
Blood
, vol.105
, pp. 1851-1861
-
-
Monti, S.1
Savage, K.J.2
Kutok, J.L.3
Feuerhake, F.4
Kurtin, P.5
Mihm, M.6
Wu, B.7
Pasqualucci, L.8
Neuberg, D.9
Aguiar, R.C.10
Dal Cin, P.11
Ladd, C.12
Pinkus, G.S.13
Salles, G.14
Harris, N.L.15
Dalla-Favera, R.16
Habermann, T.M.17
Aster, J.C.18
Golub, T.R.19
Shipp, M.A.20
more..
-
4
-
-
0037142053
-
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
-
10.1056/NEJMoa012914 12075054 10.1056/NEJMoa012914
-
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947. doi: 10.1056/NEJMoa012914
-
(2002)
N Engl J Med
, vol.346
, pp. 1937-1947
-
-
Rosenwald, A.1
Wright, G.2
Chan, W.C.3
Connors, J.M.4
Campo, E.5
Fisher, R.I.6
Gascoyne, R.D.7
Muller-Hermelink, H.K.8
Smeland, E.B.9
Giltnane, J.M.10
Hurt, E.M.11
Zhao, H.12
Averett, L.13
Yang, L.14
Wilson, W.H.15
Jaffe, E.S.16
Simon, R.17
Klausner, R.D.18
Powell, J.19
Duffey, P.L.20
Longo, D.L.21
Greiner, T.C.22
Weisenburger, D.D.23
Sanger, W.G.24
Dave, B.J.25
Lynch, J.C.26
Vose, J.27
Armitage, J.O.28
Montserrat, E.29
Lopez-Guillermo, A.30
Grogan, T.M.31
Miller, T.P.32
Leblanc, M.33
Ott, G.34
Kvaloy, S.35
Delabie, J.36
Holte, H.37
Krajci, P.38
Stokke, T.39
Staudt, L.M.40
more..
-
5
-
-
84870510099
-
Activity and complexes of mTOR in diffuse large B-cell lymphomas - A tissue microarray study
-
10.1038/modpathol.2012.141 1:CAS:528:DC%2BC38XhslKgtrfI
-
Sebestyen A, Sticz TB, Mark A, Hajdu M, Timar B, Nemes K, Nagy N, Varadi Z, Kopper L (2012) Activity and complexes of mTOR in diffuse large B-cell lymphomas - a tissue microarray study. Mod Pathol Off J U S Canad Acad Pathol Inc 25:1623-1628. doi: 10.1038/modpathol.2012.141
-
(2012)
Mod Pathol off J U S Canad Acad Pathol Inc
, vol.25
, pp. 1623-1628
-
-
Sebestyen, A.1
Sticz, T.B.2
Mark, A.3
Hajdu, M.4
Timar, B.5
Nemes, K.6
Nagy, N.7
Varadi, Z.8
Kopper, L.9
-
6
-
-
84884944145
-
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
-
10.3324/haematol.2013.086173 23716551 10.3324/haematol.2013.086173
-
Valera A, Lopez-Guillermo A, Cardesa-Salzmann T, Climent F, Gonzalez-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martinez D, Castillo P, Rovira J, Martinez A, Campo E, Colomo L (2013) MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Haematologica 98:1554-1562. doi: 10.3324/haematol.2013.086173
-
(2013)
Haematologica
, vol.98
, pp. 1554-1562
-
-
Valera, A.1
Lopez-Guillermo, A.2
Cardesa-Salzmann, T.3
Climent, F.4
Gonzalez-Barca, E.5
Mercadal, S.6
Espinosa, I.7
Novelli, S.8
Briones, J.9
Mate, J.L.10
Salamero, O.11
Sancho, J.M.12
Arenillas, L.13
Serrano, S.14
Erill, N.15
Martinez, D.16
Castillo, P.17
Rovira, J.18
Martinez, A.19
Campo, E.20
Colomo, L.21
more..
-
8
-
-
0032741530
-
Primary non-Hodgkin's lymphoma of bone: A clinicopathological investigation of 60 cases
-
1:STN:280:DC%2BD3c%2FntFSruw%3D%3D 10.1038/sj.leu.2401582
-
Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, Kluin PM (1999) Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leuk Off J Leuk Soc Am Leuk Res Fund UK 13:2094-2098
-
(1999)
Leuk off J Leuk Soc Am Leuk Res Fund UK
, vol.13
, pp. 2094-2098
-
-
Heyning, F.H.1
Hogendoorn, P.C.2
Kramer, M.H.3
Hermans, J.4
Kluin-Nelemans, J.C.5
Noordijk, E.M.6
Kluin, P.M.7
-
9
-
-
33747133748
-
Primary bone lymphoma: A retrospective analysis
-
1:STN:280:DC%2BD283mtVensg%3D%3D 16685458
-
Horsman JM, Thomas J, Hough R, Hancock BW (2006) Primary bone lymphoma: a retrospective analysis. Int J Oncol 28:1571-1575
-
(2006)
Int J Oncol
, vol.28
, pp. 1571-1575
-
-
Horsman, J.M.1
Thomas, J.2
Hough, R.3
Hancock, B.W.4
-
10
-
-
33846554856
-
A clinicopathological retrospective study of 131 patients with primary bone lymphoma: A population-based study of successively treated cohorts from the British Columbia Cancer Agency
-
10.1093/annonc/mdl329 1:STN:280:DC%2BD2s%2FisVWnsg%3D%3D 10.1093/annonc/mdl329
-
Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol Off J Eur Soc Med Oncol/ESMO 18:129-135. doi: 10.1093/annonc/mdl329
-
(2007)
Ann Oncol off J Eur Soc Med Oncol/ESMO
, vol.18
, pp. 129-135
-
-
Ramadan, K.M.1
Shenkier, T.2
Sehn, L.H.3
Gascoyne, R.D.4
Connors, J.M.5
-
11
-
-
49049117994
-
Primary diffuse large B-cell lymphomas of the bone: Prognostic relevance of protein expression and clinical factors
-
10.1016/j.humpath.2008.01.004 1:CAS:528:DC%2BD1cXhtVSjur%2FM 18614198 10.1016/j.humpath.2008.01.004
-
Adams H, Tzankov A, d'Hondt S, Jundt G, Dirnhofer S, Went P (2008) Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors. Hum Pathol 39:1323-1330. doi: 10.1016/j.humpath.2008.01.004
-
(2008)
Hum Pathol
, vol.39
, pp. 1323-1330
-
-
Adams, H.1
Tzankov, A.2
D'Hondt, S.3
Jundt, G.4
Dirnhofer, S.5
Went, P.6
-
12
-
-
33745198264
-
Primary bone lymphoma: Treatment results and prognostic factors with long-term follow-up of 82 patients
-
10.1002/cncr.21930 16700039 10.1002/cncr.21930
-
Beal K, Allen L, Yahalom J (2006) Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 106:2652-2656. doi: 10.1002/cncr.21930
-
(2006)
Cancer
, vol.106
, pp. 2652-2656
-
-
Beal, K.1
Allen, L.2
Yahalom, J.3
-
13
-
-
0041386253
-
Diffuse large B-cell lymphoma of bone: An analysis of differentiation-associated antigens with clinical correlation
-
12960812 10.1097/00000478-200309000-00011
-
de Leval L, Braaten KM, Ancukiewicz M, Kiggundu E, Delaney T, Mankin HJ, Harris NL (2003) Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 27:1269-1277
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1269-1277
-
-
De Leval, L.1
Braaten, K.M.2
Ancukiewicz, M.3
Kiggundu, E.4
Delaney, T.5
Mankin, H.J.6
Harris, N.L.7
-
14
-
-
70349125379
-
Primary lymphoma of bone: Extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype
-
10.1136/jcp.2008.063156 1:STN:280:DC%2BD1MngvVSlsw%3D%3D 19734480 10.1136/jcp.2008.063156
-
Heyning FH, Hogendoorn PC, Kramer MH, Holland CT, Dreef E, Jansen PM (2009) Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype. J Clin Pathol 62:820-824. doi: 10.1136/jcp.2008.063156
-
(2009)
J Clin Pathol
, vol.62
, pp. 820-824
-
-
Heyning, F.H.1
Hogendoorn, P.C.2
Kramer, M.H.3
Holland, C.T.4
Dreef, E.5
Jansen, P.M.6
-
15
-
-
70349656096
-
Primary bone diffuse large B-cell lymphoma: Clinicopathologic study of 21 cases and review of literature
-
10.1097/PAS.0b013e3181b314ce 19675454 10.1097/PAS.0b013e3181b314ce
-
Bhagavathi S, Micale MA, Les K, Wilson JD, Wiggins ML, Fu K (2009) Primary bone diffuse large B-cell lymphoma: clinicopathologic study of 21 cases and review of literature. Am J Surg Pathol 33:1463-1469. doi: 10.1097/PAS.0b013e3181b314ce
-
(2009)
Am J Surg Pathol
, vol.33
, pp. 1463-1469
-
-
Bhagavathi, S.1
Micale, M.A.2
Les, K.3
Wilson, J.D.4
Wiggins, M.L.5
Fu, K.6
-
16
-
-
84876083752
-
Nuclear factor-kappaB activation in primary lymphoma of bone
-
10.1007/s00428-013-1372-x 1:CAS:528:DC%2BC3sXjsFOitrk%3D 10.1007/s00428-013-1372-x
-
Koens L, Heyning FH, Szepesi A, Matolcsy A, Hogendoorn PC, Jansen PM (2013) Nuclear factor-kappaB activation in primary lymphoma of bone. Virchows Arch Int J Pathol 462:349-354. doi: 10.1007/s00428-013-1372-x
-
(2013)
Virchows Arch Int J Pathol
, vol.462
, pp. 349-354
-
-
Koens, L.1
Heyning, F.H.2
Szepesi, A.3
Matolcsy, A.4
Hogendoorn, P.C.5
Jansen, P.M.6
-
17
-
-
84867088456
-
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
-
10.1200/jco.2011.41.0985 1:CAS:528:DC%2BC38XhslSksrfI 10.1200/JCO.2011.41.0985
-
Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, Rimsza LM, Valentino C, Brunhoeber P, Grogan TM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, Rosenwald A, Ott G, Delabie J, Holcroft C, Jaffe ES, Staudt LM, Gascoyne RD (2012) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol Off J Am Soc Clin Oncol 30:3452-3459. doi: 10.1200/jco.2011.41.0985
-
(2012)
J Clin Oncol off J Am Soc Clin Oncol
, vol.30
, pp. 3452-3459
-
-
Johnson, N.A.1
Slack, G.W.2
Savage, K.J.3
Connors, J.M.4
Ben-Neriah, S.5
Rogic, S.6
Scott, D.W.7
Tan, K.L.8
Steidl, C.9
Sehn, L.H.10
Chan, W.C.11
Iqbal, J.12
Meyer, P.N.13
Lenz, G.14
Wright, G.15
Rimsza, L.M.16
Valentino, C.17
Brunhoeber, P.18
Grogan, T.M.19
Braziel, R.M.20
Cook, J.R.21
Tubbs, R.R.22
Weisenburger, D.D.23
Campo, E.24
Rosenwald, A.25
Ott, G.26
Delabie, J.27
Holcroft, C.28
Jaffe, E.S.29
Staudt, L.M.30
Gascoyne, R.D.31
more..
-
18
-
-
79951990286
-
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
-
10.1200/jco.2010.30.0368 10.1200/JCO.2010.30.0368
-
Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol Off J Am Soc Clin Oncol 29:200-207. doi: 10.1200/jco.2010.30.0368
-
(2011)
J Clin Oncol off J Am Soc Clin Oncol
, vol.29
, pp. 200-207
-
-
Meyer, P.N.1
Fu, K.2
Greiner, T.C.3
Smith, L.M.4
Delabie, J.5
Gascoyne, R.D.6
Ott, G.7
Rosenwald, A.8
Braziel, R.M.9
Campo, E.10
Vose, J.M.11
Lenz, G.12
Staudt, L.M.13
Chan, W.C.14
Weisenburger, D.D.15
-
19
-
-
9144237554
-
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
-
10.1182/blood-2003-05-1545 1:CAS:528:DC%2BD2cXhsFGhsA%3D%3D 14504078 10.1182/blood-2003-05-1545
-
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282. doi: 10.1182/blood-2003-05-1545
-
(2004)
Blood
, vol.103
, pp. 275-282
-
-
Hans, C.P.1
Weisenburger, D.D.2
Greiner, T.C.3
Gascoyne, R.D.4
Delabie, J.5
Ott, G.6
Muller-Hermelink, H.K.7
Campo, E.8
Braziel, R.M.9
Jaffe, E.S.10
Pan, Z.11
Farinha, P.12
Smith, L.M.13
Falini, B.14
Banham, A.H.15
Rosenwald, A.16
Staudt, L.M.17
Connors, J.M.18
Armitage, J.O.19
Chan, W.C.20
more..
-
20
-
-
79956196878
-
Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein
-
10.1007/s00418-011-0803-5 1:CAS:528:DC%2BC3MXjvVSksrs%3D 21424608 10.1007/s00418-011-0803-5
-
Egervari G, Mark A, Hajdu M, Barna G, Sapi Z, Krenacs T, Kopper L, Sebestyen A (2011) Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein. Histochem Cell Biol 135:409-417. doi: 10.1007/s00418-011-0803-5
-
(2011)
Histochem Cell Biol
, vol.135
, pp. 409-417
-
-
Egervari, G.1
Mark, A.2
Hajdu, M.3
Barna, G.4
Sapi, Z.5
Krenacs, T.6
Kopper, L.7
Sebestyen, A.8
-
21
-
-
38349068502
-
Lymphoma microenvironment: Culprit or innocent?
-
10.1038/sj.leu.2404970 1:STN:280:DC%2BD1c%2Fkt1KktQ%3D%3D 10.1038/sj.leu.2404970
-
Herreros B, Sanchez-Aguilera A, Piris MA (2008) Lymphoma microenvironment: culprit or innocent? Leuk Off J Leuk Soc Am Leuk Res Fund UK 22:49-58. doi: 10.1038/sj.leu.2404970
-
(2008)
Leuk off J Leuk Soc Am Leuk Res Fund UK
, vol.22
, pp. 49-58
-
-
Herreros, B.1
Sanchez-Aguilera, A.2
Piris, M.A.3
-
22
-
-
42249094550
-
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
-
10.1111/j.1365-2141.2008.07037.x 1:CAS:528:DC%2BD1cXnt1eisrc%3D 18419622 10.1111/j.1365-2141.2008.07037.x
-
Linderoth J, Eden P, Ehinger M, Valcich J, Jerkeman M, Bendahl PO, Berglund M, Enblad G, Erlanson M, Roos G, Cavallin-Stahl E (2008) Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma. Br J Haematol 141:423-432. doi: 10.1111/j.1365-2141.2008.07037.x
-
(2008)
Br J Haematol
, vol.141
, pp. 423-432
-
-
Linderoth, J.1
Eden, P.2
Ehinger, M.3
Valcich, J.4
Jerkeman, M.5
Bendahl, P.O.6
Berglund, M.7
Enblad, G.8
Erlanson, M.9
Roos, G.10
Cavallin-Stahl, E.11
-
23
-
-
0035253726
-
Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome
-
1:STN:280:DC%2BD3M7kvV2lsg%3D%3D
-
Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE (2001) Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol Off J Am Soc Clin Oncol 19:720-726
-
(2001)
J Clin Oncol off J Am Soc Clin Oncol
, vol.19
, pp. 720-726
-
-
Ansell, S.M.1
Stenson, M.2
Habermann, T.M.3
Jelinek, D.F.4
Witzig, T.E.5
-
24
-
-
2542429298
-
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
-
10.1182/blood-2003-07-2365 1:CAS:528:DC%2BD2cXkvVyitL0%3D 14976040 10.1182/blood-2003-07-2365
-
Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM (2004) Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103:4251-4258. doi: 10.1182/blood-2003-07-2365
-
(2004)
Blood
, vol.103
, pp. 4251-4258
-
-
Rimsza, L.M.1
Roberts, R.A.2
Miller, T.P.3
Unger, J.M.4
Leblanc, M.5
Braziel, R.M.6
Weisenberger, D.D.7
Chan, W.C.8
Muller-Hermelink, H.K.9
Jaffe, E.S.10
Gascoyne, R.D.11
Campo, E.12
Fuchs, D.A.13
Spier, C.M.14
Fisher, R.I.15
Delabie, J.16
Rosenwald, A.17
Staudt, L.M.18
Grogan, T.M.19
-
25
-
-
34247549368
-
The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
-
10.1111/j.1365-2141.2007.06593.x 1:CAS:528:DC%2BD2sXntVSntbo%3D 17456059 10.1111/j.1365-2141.2007.06593.x
-
Hasselblom S, Sigurdadottir M, Hansson U, Nilsson-Ehle H, Ridell B, Andersson PO (2007) The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma. Br J Haematol 137:364-373. doi: 10.1111/j.1365-2141.2007.06593.x
-
(2007)
Br J Haematol
, vol.137
, pp. 364-373
-
-
Hasselblom, S.1
Sigurdadottir, M.2
Hansson, U.3
Nilsson-Ehle, H.4
Ridell, B.5
Andersson, P.O.6
-
26
-
-
83055181891
-
The four types of Tregs in malignant lymphomas
-
10.1186/1756-8722-4-50 3253040 22151904 10.1186/1756-8722-4-50
-
Wang J, Ke XY (2011) The four types of Tregs in malignant lymphomas. J Hematol Oncol 4:50. doi: 10.1186/1756-8722-4-50
-
(2011)
J Hematol Oncol
, vol.4
, pp. 50
-
-
Wang, J.1
Ke, X.Y.2
-
27
-
-
1542503860
-
Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas
-
10.1038/sj.leu.2403240 1:CAS:528:DC%2BD2cXhsV2qs7k%3D 10.1038/sj.leu.2403240
-
Muris JJ, Meijer CJ, Cillessen SA, Vos W, Kummer JA, Bladergroen BA, Bogman MJ, MacKenzie MA, Jiwa NM, Siegenbeek van Heukelom LH, Ossenkoppele GJ, Oudejans JJ (2004) Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leuk Off J Leuk Soc Am Leuk Res Fund UK 18:589-596. doi: 10.1038/sj.leu.2403240
-
(2004)
Leuk off J Leuk Soc Am Leuk Res Fund UK
, vol.18
, pp. 589-596
-
-
Muris, J.J.1
Meijer, C.J.2
Cillessen, S.A.3
Vos, W.4
Kummer, J.A.5
Bladergroen, B.A.6
Bogman, M.J.7
Mackenzie, M.A.8
Jiwa, N.M.9
Siegenbeek Van Heukelom, L.H.10
Ossenkoppele, G.J.11
Oudejans, J.J.12
-
28
-
-
84868003454
-
High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
-
10.1007/s12032-011-0123-6 10.1007/s12032-011-0123-6
-
Cai QC, Liao H, Lin SX, Xia Y, Wang XX, Gao Y, Lin ZX, Lu JB, Huang HQ (2012) High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Med Oncol (Northwood, London, England) 29:2317-2322. doi: 10.1007/s12032-011-0123-6
-
(2012)
Med Oncol (Northwood, London, England)
, vol.29
, pp. 2317-2322
-
-
Cai, Q.C.1
Liao, H.2
Lin, S.X.3
Xia, Y.4
Wang, X.X.5
Gao, Y.6
Lin, Z.X.7
Lu, J.B.8
Huang, H.Q.9
-
29
-
-
40849126992
-
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
-
10.3324/haematol.11702 1:CAS:528:DC%2BD1cXhsVSiu7zN 18223287 10.3324/haematol.11702
-
Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93:193-200. doi: 10.3324/haematol.11702
-
(2008)
Haematologica
, vol.93
, pp. 193-200
-
-
Tzankov, A.1
Meier, C.2
Hirschmann, P.3
Went, P.4
Pileri, S.A.5
Dirnhofer, S.6
-
30
-
-
70449346541
-
Primary bone lymphoma
-
10.1043/1543-2165-133.11.1868 19886726
-
Bhagavathi S, Fu K (2009) Primary bone lymphoma. Arch Pathol Lab Med 133:1868-1871. doi: 10.1043/1543-2165-133.11.1868
-
(2009)
Arch Pathol Lab Med
, vol.133
, pp. 1868-1871
-
-
Bhagavathi, S.1
Fu, K.2
-
31
-
-
77954713699
-
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP
-
10.1111/j.1600-0609.2010.01467.x 1:CAS:528:DC%2BC3cXhtVOntbzE 20477862
-
Yoon DH, Choi DR, Ahn HJ, Kim S, Lee DH, Kim SW, Park BH, Yoon SO, Huh J, Lee SW, Suh C (2010) Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. Eur J Haematol 85:149-157. doi: 10.1111/j.1600-0609.2010.01467.x
-
(2010)
Eur J Haematol
, vol.85
, pp. 149-157
-
-
Yoon, D.H.1
Choi, D.R.2
Ahn, H.J.3
Kim, S.4
Lee, D.H.5
Kim, S.W.6
Park, B.H.7
Yoon, S.O.8
Huh, J.9
Lee, S.W.10
Suh, C.11
-
32
-
-
33845501828
-
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival
-
10.1182/blood-2006-04-016907 1:CAS:528:DC%2BD28XhtlWqsrjK 16946303 10.1182/blood-2006-04-016907
-
Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, Moorji A, Atizado V, Al-Dayel F, Belgaumi A, El-Solh H, Ezzat A, Bavi P, Al-Kuraya KS (2006) Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108:4178-4186. doi: 10.1182/blood-2006-04-016907
-
(2006)
Blood
, vol.108
, pp. 4178-4186
-
-
Uddin, S.1
Hussain, A.R.2
Siraj, A.K.3
Manogaran, P.S.4
Al-Jomah, N.A.5
Moorji, A.6
Atizado, V.7
Al-Dayel, F.8
Belgaumi, A.9
El-Solh, H.10
Ezzat, A.11
Bavi, P.12
Al-Kuraya, K.S.13
-
33
-
-
79751526328
-
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
-
10.1038/leu.2010.226 1:CAS:528:DC%2BC3MXhs1amsL4%3D 10.1038/leu.2010.226
-
Witzig TE, Reeder CB, LaPlant BR, Gupta M, Johnston PB, Micallef IN, Porrata LF, Ansell SM, Colgan JP, Jacobsen ED, Ghobrial IM, Habermann TM (2011) A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma. Leuk Off J Leuk Soc Am Leuk Res Fund UK 25:341-347. doi: 10.1038/leu.2010.226
-
(2011)
Leuk off J Leuk Soc Am Leuk Res Fund UK
, vol.25
, pp. 341-347
-
-
Witzig, T.E.1
Reeder, C.B.2
Laplant, B.R.3
Gupta, M.4
Johnston, P.B.5
Micallef, I.N.6
Porrata, L.F.7
Ansell, S.M.8
Colgan, J.P.9
Jacobsen, E.D.10
Ghobrial, I.M.11
Habermann, T.M.12
|